Silvia Novello, MD, PhD, on NSCLC Treatment Guided by Pharmacogenomics

Posted: Monday, February 8, 2021

Silvia Novello, MD, PhD, of the University of Turin, talks about how findings from the phase III ITACA trial on customizing treatment might influence clinical decision-making for patients with completely resected stage II to IIIA non–small cell lung cancer.